Dear Colleague,
We all face similar challenges in designing and validating assays and bioprocesses. Whether trying to secure cell sources that reliably present conditions of interest, determining criteria to identify and eliminate outlier results, or designing assays sensitive enough to track ultra low-abundance proteins, each step involves performance trade-offs that must be carefully considered and accounted for. And ultimately we all seek to design methods with proven transferability and clinical utility.
That is why I would like to invite you to attend IIR’s 7th Annual Cell Based Assays and BioAnalytical Method Development conference, to be held October 3-5, 2011 at the Claremont Hotel Club & Spa in Berkeley, CA. This year’s event will feature nearly 40 speakers, and will continue to offer the small-format discussions and troubleshooting sessions you have come to expect. To learn more, download the latest conference brochure.
Some of the topics we will cover include:
• Strategies for control and assessment of Fc effector functions of therapeutic antibodies
• A rapid approach to developing reporter cell lines for bioassays
• Bioanalytical test elements that facilitate comparability studies for the development of biosimilars
• Virus neutralization assays using multiple image-based technology platforms
For more information, download the event brochure.
Thank you very much, and I look forward to welcoming you to this event in October.
Sincerely,
Shan Chung, PhD
Scientist, Bioanalytical Sciences, Genentech
Co-Chair, Cell Based Assays and BioAnalytical Method Development 2011
As a reader of the Future of Biopharma Blog, register for this event with the special Priority Code XP1668Blog, to receive 25% off the standard rate! If you have any questions about the event, please feel free to contact Jennifer Pereira at jpereira@iirusa.com. Register by emailing register@iirusa.com.
Share this article with your social network, just click below to share now!
|
|
No comments :
Post a Comment